miR-126 functions as a tumour suppressor in human gastric cancer.
about
Insights into the Regulatory Role of Non-coding RNAs in Cancer MetabolismPotential Diagnostic, Prognostic and Therapeutic Targets of MicroRNAs in Human Gastric CancerDysregulation of non-coding RNAs in gastric cancerPrognostic Role of MicroRNA-126 for Survival in Malignant Tumors: A Systematic Review and Meta-AnalysisClinical application of microRNA in gastric cancer in Eastern Asian areaDomain organization differences explain Bcr-Abl's preference for CrkL over CrkIImicroRNA-126 suppresses PAK4 expression in ovarian cancer SKOV3 cellsPrometastatic GPCR CD97 is a direct target of tumor suppressor microRNA-126Embryonic atrazine exposure alters zebrafish and human miRNAs associated with angiogenesis, cancer, and neurodevelopmentMicroRNAs targeting oncogenes are down-regulated in pancreatic malignant transformation from benign tumorsIdentification of miRs-143 and -145 that is associated with bone metastasis of prostate cancer and involved in the regulation of EMTPhosphatidylinositol transfer proteins and instructive regulation of lipid kinase biologyCrk at the quarter century mark: perspectives in signaling and cancer.Models of crk adaptor proteins in cancer.The role of miRNAs in bone metastasis and their significance in the detection of bone metastasis: a review of the published data.MiR-133b is frequently decreased in gastric cancer and its overexpression reduces the metastatic potential of gastric cancer cells.miR-1207-5p and miR-1266 suppress gastric cancer growth and invasion by targeting telomerase reverse transcriptase.Lessons from miR-143/145: the importance of cell-type localization of miRNAsMiRNA as potential biomarkers and therapeutic targets for gastric cancer.Microribonucleic acids and gastric cancer.A microRNA regulon that mediates endothelial recruitment and metastasis by cancer cells.Down-regulated miR-625 suppresses invasion and metastasis of gastric cancer by targeting ILK.MiR-126-3p suppresses tumor metastasis and angiogenesis of hepatocellular carcinoma by targeting LRP6 and PIK3R2.MicroRNA-126 inhibits tumor cell growth and its expression level correlates with poor survival in non-small cell lung cancer patients.SIRT2 plays a key role in both cell cycle regulation and cell survival of BV2 microglia.Determination of reference microRNAs for relative quantification in porcine tissues.let-7b and miR-126 are down-regulated in tumor tissue and correlate with microvessel density and survival outcomes in non--small--cell lung cancer.MicroRNA-126 suppresses mesothelioma malignancy by targeting IRS1 and interfering with the mitochondrial functionmicroRNAs Distinctively Regulate Vascular Smooth Muscle and Endothelial Cells: Functional Implications in Angiogenesis, Atherosclerosis, and In-Stent Restenosis.Up-regulation of microRNA-126 may contribute to pathogenesis of ulcerative colitis via regulating NF-kappaB inhibitor IκBα.Oncogenic activity of the regulatory subunit p85β of phosphatidylinositol 3-kinase (PI3K)Different miRNA signatures of oral and pharyngeal squamous cell carcinomas: a prospective translational study.Epigenetic silencing of miR-338-3p contributes to tumorigenicity in gastric cancer by targeting SSX2IP.Decrease of miR-202-3p expression, a novel tumor suppressor, in gastric cancer.Emerging roles for crk in human cancer.Decreased expression of microRNA-126 is associated with poor prognosis in patients with cervical cancer.Regulation of cancer metastasis by microRNAs.Reduced miR-126 expression facilitates angiogenesis of gastric cancer through its regulation on VEGF-APlasma microRNAs as potential biomarkers for non-small-cell lung cancerDown-regulation of tissue microRNA-126 was associated with poor prognosis in patients with cutaneous melanoma.
P2860
Q26739857-E7FB2669-55DD-41DE-984D-8858C79BBF67Q26744362-ACD66010-79CD-4034-AB2A-0A91AB297F18Q26780293-13B0727C-A1FB-4C47-8175-FDB9204723C4Q26782492-CD68419F-3F4E-4011-8F6C-CFF56CB86900Q26829583-D79BBDDD-2A18-4E0B-98A2-F32C9AF7A225Q27679069-B21A8F4C-EAB5-45E8-A947-BCC50E7E2938Q28264476-C6F261E1-8FC2-4FFA-9E25-CBABD44BE873Q28302687-B0D6CC2E-AB5E-448C-BA08-A901C570FB82Q28390547-74E52DA4-51F5-425D-AB2E-E90F8ECE2967Q28731854-82A971D8-CF3D-4246-AA27-8AA854CC09A3Q28744173-14B306DE-D54A-4216-B705-0D94E019508BQ28817720-BE30BFDC-0FDF-4B05-98D8-FF16B3BEC405Q30009510-C91FD89B-EDD8-4F5C-B503-58E477827EE9Q30009961-78457063-97BD-4EA2-A058-BD9CADD96F1CQ30883662-F4CA58A6-376B-420B-BA65-F6DA15FBD6C5Q31148368-9CB49874-6838-48B5-A977-2BDFB37546CBQ33695070-DAC2D96B-5DAD-4375-B29D-1454201886F2Q33843116-5C20E3F8-F81B-4C3D-AB75-FC3C5EB57DD0Q34036679-58CF7619-3F61-4924-9FA4-9BB4254CA660Q34240588-8C3BA4EF-0E98-4546-BB8A-89110D55A14EQ34240754-5E5D880F-8E24-47F5-8D24-7B428656A33CQ34279682-EB951987-EE66-4C1D-9C77-F137EAE8D853Q34306118-E7BEACC1-1DA1-487A-BB0E-C7C622744265Q34382704-7B27353D-6D71-4CEE-A75C-4C782A4D9603Q34400393-876D5529-8053-411B-B2A2-704653EF75D8Q34412383-5301CB2C-32FF-43E2-B4E4-A667AAB98485Q34429485-C76A64D0-9D01-454B-88DC-C5CDB7244034Q34431793-DA3BE94F-1B9A-4450-A197-BC675E99E97DQ34504964-31359E5E-DAB3-47E7-A6B1-1783B056C5AFQ34534594-E5219B50-FDEE-4721-B04B-BD1EFCB7EC50Q34601157-686FBC93-23EA-462F-829B-BA76EFF98909Q34621889-3D54C914-F975-4010-9AAC-A98B808BBDECQ34795973-D5602DD8-43D1-4EA6-85AA-F14883738A0BQ34921140-27AB524E-D0B6-44D2-BC9D-F28A28CA385DQ34972759-78E49015-C2D2-44CE-A6DA-401B0F15582AQ34987355-E9127B2C-2C3C-4529-A881-038427DF400CQ35052860-255AED04-D0EA-4EA7-B6B2-E604CC8A1AF1Q35067942-5A76BD93-2623-4FB7-92A2-1432C95F1EC0Q35087819-437DCBEF-6477-4222-9F7D-7C8CA31B7B1EQ35644010-6418B345-4933-49C5-885B-1D7457614ABD
P2860
miR-126 functions as a tumour suppressor in human gastric cancer.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
miR-126 functions as a tumour suppressor in human gastric cancer.
@ast
miR-126 functions as a tumour suppressor in human gastric cancer.
@en
miR-126 functions as a tumour suppressor in human gastric cancer.
@nl
type
label
miR-126 functions as a tumour suppressor in human gastric cancer.
@ast
miR-126 functions as a tumour suppressor in human gastric cancer.
@en
miR-126 functions as a tumour suppressor in human gastric cancer.
@nl
prefLabel
miR-126 functions as a tumour suppressor in human gastric cancer.
@ast
miR-126 functions as a tumour suppressor in human gastric cancer.
@en
miR-126 functions as a tumour suppressor in human gastric cancer.
@nl
P2093
P1433
P1476
miR-126 functions as a tumour suppressor in human gastric cancer.
@en
P2093
Bingya Liu
Jianfang Li
Runhua Feng
Xuehua Chen
Yingyan Yu
Zhenggang Zhu
P356
10.1016/J.CANLET.2010.06.004
P407
P577
2010-07-08T00:00:00Z